Miriam Kidron, Chief Technology Officer at ORAMED PHARMACEUTICALS INC. (ORMP), sold 137,300 shares at $12.03 ($1.7M) on 2014-04-01, disclosed to the SEC on 2014-04-03.
Open-market sale of $1.7M ORMP by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2017-04-19 | $669K | — | Filing → |
| ORMP | SELL | 2015-12-31 | $445K | — | Filing → |
| ORMP | SELL | 2014-09-12 | $267K | — | Filing → |